Prediction of progression-free survival
โ
Massimo De Giorgio; Stefano Vezzoli; Eric Cohen; Elia Armellini; Maria Grazia Lu
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 265 KB
Transplantation is the treatment of choice for hepatocellular carcinoma (HCC) meeting the Milan criteria. HCC and chronic liver diseases have distinct natural histories for which an equitable transplant policy must account. We enrolled and prospectively followed at a single center 206 consecutive HC